Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 26, 2023

BUY
$90.27 - $105.39 $213,308 - $249,036
2,363 Added 9.91%
26,217 $2.55 Million
Q4 2022

Jan 23, 2023

BUY
$84.0 - $104.29 $3,780 - $4,693
45 Added 0.19%
23,854 $0
Q3 2022

Oct 31, 2022

SELL
$83.01 - $101.72 $98,200 - $120,334
-1,183 Reduced 4.73%
23,809 $1.98 Million
Q2 2022

Jul 25, 2022

BUY
$95.66 - $108.57 $1.83 Million - $2.07 Million
19,082 Added 322.88%
24,992 $2.47 Million
Q1 2022

May 03, 2022

BUY
$88.87 - $111.9 $525,221 - $661,329
5,910 New
5,910 $555,000
Q1 2018

May 08, 2018

SELL
$95.63 - $110.6 $199,388 - $230,601
-2,085 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$102.05 - $115.17 $511,780 - $577,577
-5,015 Reduced 70.63%
2,085 $220,000
Q3 2017

Nov 08, 2017

BUY
$111.01 - $118.92 $788,171 - $844,332
7,100
7,100 $788,000

Others Institutions Holding PM

About Philip Morris International Inc.


  • Ticker PM
  • Exchange NYSE
  • Sector Consumer Defensive
  • Industry Tobacco
  • Shares Outstandng 1,550,160,000
  • Market Cap $202B
  • Description
  • Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine...
More about PM
Track This Portfolio

Track Geneva Partners, LLC Portfolio

Follow Geneva Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneva Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geneva Partners, LLC with notifications on news.